Gordon Research Conferences
Meeting Details
Search:
  GO

Cancer Nanotechnology
Gordon Research Conference

Nanomedicines from Laboratory to Clinical Reality

Dates

June 28 - July 3, 2015

Location

Mount Snow
West Dover, VT

Organizers

Chair:
Leaf Huang

Vice Chair:
Alexander V. Kabanov

Meeting Description

Nanotechnology is a burgeoning field of study in science and engineering. Its application for cancer diagnosis, imaging, therapy, and prognosis has been a focal point of attention in nanomedicine. Due to the presence of leaky vasculature and defective lymphatic drainage in solid tumors, nanoparticles selectively accumulate in the tumor via the mechanism of the enhanced permeability and retention (EPR) effect. Thus, nanoparticles are uniquely suitable for delivering diagnostic and/or imaging agents, chemo and gene drugs, and agents to enhance the activity of immunotherapy to the tumor. Nanoparticles also offer an amplification mechanism for bioanalytical detection and sensor devices for cancer markers. It is not surprising that the number of publications in cancer nanotechnology had increased rapidly to about 500-600 per year. This is strong evidence that cancer nanotechnology is already an established field of study. This conference will serve as a major forum of information exchange and personnel networking in the relaxed setting of a Gordon Research Conference. The conference program will include: tumor microenvironment; chemodrugs delivered by nanoparticles; stealth mechanism and improvement in nanoparticles; gene/siRNA delivery; immunotherapy and nano-vaccines; novel nano materials; early diagnosis of cancer; tumor imaging; clinical trials.

Contributors

Final Meeting Program

Sunday
2:00 pm - 9:00 pmArrival and Check-in
6:00 pmDinner
7:30 pm - 7:40 pmWelcome / Introductory Comments by GRC Site Staff
7:40 pm - 9:30 pmCancer Microenvironment
Discussion Leader: Leaf Huang (University of North Carolina, USA)
7:40 pm - 8:15 pmBiana Godin Vilentchouk (Houston Methodist Research Institute, USA)
"Exploiting Elements of Tumor Stroma for Enhanced Transport of Nanotherapeutics"
8:15 pm - 8:35 pmDiscussion
8:35 pm - 9:10 pmDouglas Fearon (Cold Spring Harbor Laboratory, USA)
"Immune Privilege by T Cell Exclusion from the Tumor Microenvironment"
9:10 pm - 9:30 pmDiscussion
Monday
7:30 am - 8:30 amBreakfast
9:00 am - 12:30 pmChemo Drugs
Discussion Leader: Biana Godin Vilentchouk (Houston Methodist Research Institute, USA)
9:00 am - 9:40 amKazunori Kataoka (University of Tokyo, Japan)
"Polymeric Micellar Nanomedicines for the Treatment of Recalcitrant Cancer Stem Cells"
9:40 am - 10:00 amDiscussion
10:00 am - 10:30 amCoffee Break
10:30 am - 11:10 amPuja Sapra (Pfizer, USA)
"Antibody-Drug Conjugates: Achievements, Challenges and Future"
11:10 am - 11:30 amDiscussion
11:30 am - 12:10 pmYuliang Zhao (Chinese Academy of Sciences, China)
"Prison Instead of Poison Cancer Cells by Nanoparticle Targeting Cancer Stem Cells"
12:10 pm - 12:30 pmDiscussion
12:30 pmLunch
1:30 pm - 4:00 pmFree Time
4:00 pm - 6:00 pmPoster Session
6:00 pmDinner
7:30 pm - 9:30 pmStealth Nanoparticles and Tumor Penetrating Peptides
Discussion Leader: Kazunori Kataoka (University of Tokyo, Japan)
7:30 pm - 8:10 pmShaoyi Jiang (University of Washington, USA)
"Zwitterionic Materials in Nanomedicine"
8:10 pm - 8:30 pmDiscussion
8:30 pm - 9:10 pmSamuel Lai (University of North Carolina at Chapel Hill, USA)
"Homing Nanoparticles to Molecularly Heterogenous Targets via Bi-Specific Fusion Proteins"
9:10 pm - 9:30 pmDiscussion
Tuesday
7:30 am - 8:30 amBreakfast
8:30 amGroup Photo
9:00 am - 12:30 pmVector/Host Interaction
Discussion Leader: Carlos Rinaldi (University of Florida, USA)
9:00 am - 9:40 amRonit Satchi-Fainaro (Sackler School of Medicine, Tel Aviv University, Israel)
"Interfering Tumor-Host Interactions with Theranostic Nanomedicines"
9:40 am - 10:00 amDiscussion
10:00 am - 10:30 amCoffee Break
10:30 am - 11:10 amSuzie Pun (University of Washington, USA)
"Targeted Polymeric Nanostructures for Chemotherapy Delivery and Immunodulation"
11:10 am - 11:30 amDiscussion
11:30 am - 12:10 pmCarlos Rinaldi (University of Florida, USA)
"Nanoscale Thermal Phenomena in Magnetic Nanoparticles: Experimental Evidence and Potential Applications in Cancer Nanotechnology"
12:10 pm - 12:30 pmDiscussion
12:30 pmLunch
1:30 pm - 4:00 pmFree Time
4:00 pm - 6:00 pmPoster Session
6:00 pmDinner
7:30 pm - 9:30 pmNew Nanomaterials
Discussion Leader: Suzie Pun (University of Washington, USA)
7:30 pm - 8:10 pmDavid Weiner (University of Pennsylvania, USA)
"Synthetic DNA Vaccines: New Technology for Difficult Targets"
8:10 pm - 8:30 pmDiscussion
8:30 pm - 9:10 pmLiangfang Zhang (University of California, San Diego, USA)
"Cell Membrane-Coated Nanoparticles for Drug Delivery and Vaccination"
9:10 pm - 9:30 pmDiscussion
Wednesday
7:30 am - 8:30 amBreakfast
9:00 am - 12:30 pmImaging and Theranostics
Discussion Leader: Shawn Chen (National Institute of Biomedical Imaging and Bioengineering, NIH, USA)
9:00 am - 9:40 amPeixuan Guo (University of Kentucky, USA)
"RNA Nanotechnology for Cancer Targeting Using Nanoparticles with Scaffold, Ligand, and Therapeutics All Composed of RNA"
9:40 am - 10:00 amDiscussion
10:00 am - 10:30 amCoffee Break
10:30 am - 11:10 amStanislav Emelianov (Georgia Institute of Technology / Emory University School of Medicine, USA)
"In Vivo Ultrasound-Based Molecular Imaging and Image-Guided Therapy of Cancer"
11:10 am - 11:30 amDiscussion
11:30 am - 12:10 pmJianjun Cheng (University of Illinois at Urbana-Champaign, USA)
"Design of Anticancer Nanomedicine via Controlled Chemistry"
12:10 pm - 12:30 pmDiscussion
12:30 pmLunch
1:30 pm - 4:00 pmFree Time
4:00 pm - 6:00 pmPoster Session
6:00 pmDinner
7:00 pm - 7:30 pmBusiness Meeting
Nominations for the Next Vice Chair; Fill in Conference Evaluation Forms; Discuss Future Site and Scheduling Preferences; Election of the Next Vice Chair
7:30 pm - 9:30 pmEarly Diagnosis and Imaging
Discussion Leader: Liangfang Zhang (University of California, San Diego, USA)
7:30 pm - 8:10 pmShawn Chen (National Institute of Biomedical Imaging and Bioengineering, NIH, USA)
"Theranostic Nanomedicine"
8:10 pm - 8:30 pmDiscussion
8:30 pm - 9:10 pmDmitri Lapotko (Rice University, USA)
"Non-Stationary Plasmonic Nanobubbles for Cancer Theranostics"
9:10 pm - 9:30 pmDiscussion
Thursday
7:30 am - 8:30 amBreakfast
9:00 am - 12:30 pmAdvances in Nanotechnology
Discussion Leader: David Weiner (University of Pennsylvania, USA)
9:00 am - 9:40 amMuthiah Manoharan (Alnylam Pharmaceuticals, USA)
"Advances in Delivery of RNAi Therapeutics"
9:40 am - 10:00 amDiscussion
10:00 am - 10:30 amCoffee Break
10:30 am - 11:10 amBart Hendriks (Merrimack Pharmaceuticals, USA)
"Imaging the Nanoparticle EPR Effect in Human Tumors"
11:10 am - 11:30 amDiscussion
11:30 am - 12:10 pmTai Hyun Park (Seoul National University, South Korea)
"Bioelectronic Nose: Possible Application to Cancer Diagnosis."
12:10 pm - 12:30 pmDiscussion
12:30 pmLunch
1:30 pm - 4:00 pmFree Time
4:00 pm - 6:00 pmPoster Session
6:00 pmDinner
7:30 pm - 9:30 pmSelected Poster Presentations
Discussion Leader: Alexander Kabanov (University of North Carolina at Chapel Hill, USA)
7:30 pm - 7:45 pmDebadyuti Ghosh (University of Texas at Austin, USA)
"Short Wavelength-Infrared Fluorescence Nanoprobes Towards Non-Invasive Imaging and Surgical Guidance of Sub-Millimeter Tumors"
7:45 pm - 7:50 pmDiscussion
7:50 pm - 8:05 pmXiaohua Huang (The University of Memphis, USA)
"Hybrid Nanoparticles for Capture, Detection and Analysis of Rare Cancer Cells in Blood"
8:05 pm - 8:10 pmDiscussion
8:10 pm - 8:25 pmJinyao Liu (Duke University, USA)
"Developing High Paclitaxel-Loading Nanoparticles to Abolish Tumours Efficiently"
8:25 pm - 8:30 pmDiscussion
8:30 pm - 8:45 pmOmar Khan (Massachusetts Institute of Technology, USA)
"Dendrimer-Inspired Nanomaterials for Tunable Delivery of siRNA to Vasculature In Vivo"
8:45 pm - 8:50 pmDiscussion
8:50 pm - 9:05 pmPrabhani Atukorale (Case Western Reserve University, USA)
"Beyond the EPR Effect: Targeting Nanoparticles to Hard-to-Reach Tumor Sites"
9:05 pm - 9:10 pmDiscussion
9:10 pm - 9:25 pmSanyogitta Puri (AstraZeneca, United Kingdom)
"Improving Nanomedicine Translatability by Re-Considering the EPR Effect and Pre-Clinical to Clinical Research Paradigms"
9:25 pm - 9:30 pmDiscussion
Friday
7:30 am - 8:30 amBreakfast
9:00 amDeparture
© 2017 Gordon Research Conferences Search | Contact | Terms of Use | Privacy Policy | Follow us: Facebook Twitter